{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:34:08Z","timestamp":1760146448419,"version":"build-2065373602"},"reference-count":24,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Centro Nacional de Investigaciones Cardiovasculares (CNIC)","award":["CEX2020-001041-S"],"award-info":[{"award-number":["CEX2020-001041-S"]}]},{"name":"Instituto de Salud Carlos III (ISCIII)","award":["CEX2020-001041-S"],"award-info":[{"award-number":["CEX2020-001041-S"]}]},{"name":"Ministerio de Ciencia e Innovaci\u00f3n (MCIN)","award":["CEX2020-001041-S"],"award-info":[{"award-number":["CEX2020-001041-S"]}]},{"name":"Pro CNIC Foundation","award":["CEX2020-001041-S"],"award-info":[{"award-number":["CEX2020-001041-S"]}]},{"name":"MICIN\/AEI\/10.13039\/501100011033","award":["CEX2020-001041-S"],"award-info":[{"award-number":["CEX2020-001041-S"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Flow cytometry plays a fundamental role in the diagnosis of leukemias and lymphomas, as well as in the follow-up and evaluation of minimally measurable disease after treatment. In some instances, such as in the case of acute promyelocytic leukemia (APL), rapid diagnosis is required to avoid death due to serious blood clotting or bleeding complications. Given that promyelocytes do not express the glycophosphatidylinositol (GPI)-anchored protein CD16 and that deficient CD16 expression is a feature of some CD16 polymorphisms and paroxysmal nocturnal hemoglobinuria (PNH), we included the GPI anchor probe FLAER aerolysin in the APL flow cytometry probe panel. Initial tests showed that FLAER binding was absent in pathological promyelocytes from APL patients but was consistently detected with high intensity in healthy promyelocytes from control bone marrow. FLAER binding was studied in 71 hematologic malignancies. Appropriate control cells were obtained from 16 bone marrow samples from patients with idiopathic thrombocytopenic purpura and non-infiltrated non-Hodgkin\u2019s lymphoma. Compared with the positive FLAER signal in promyelocytes from healthy bone marrow, malignant promyelocytes from APL patients showed weak or negative FLAER binding. The FLAER signal in APL promyelocytes was also lower than that in control myeloid progenitors and precursors from patients with other forms of acute myeloid leukemia (AML), B-cell acute lymphoblastic leukemia, or myelodysplastic syndrome. Minimal measurable disease studies performed in APL patients after treatment found normal promyelocyte expression when minimal measurable disease was negative and FLAER-negative promyelocytes when disease relapse was detected. The inclusion of FLAER in the flow cytometry diagnosis and follow-up of APL could be very helpful. Decreased FLAER binding was found in all cases of APL, confirmed by the detection of the PML-RARA fusion transcript and, to a lesser extent, in the other AMLs studied. This study also revealed FLAER differences in other acute leukemias and even between different precursors (myeloid and lymphoid) from healthy controls. However, the reason for FLAER\u2019s non-binding to the malignant precursors of these leukemias remains unknown, and future studies should explore the possible relation with an immune escape phenomenon in these leukemias.<\/jats:p>","DOI":"10.3390\/ijms252211898","type":"journal-article","created":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T11:36:39Z","timestamp":1730806599000},"page":"11898","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Fluorescent Aerolysin (FLAER) Binding Is Abnormally Low in the Clonal Precursors of Acute Leukemias, with Binding Particularly Low or Absent in Acute Promyelocytic Leukemia"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0292-5010","authenticated-orcid":false,"given":"Mar\u00eda Beatriz","family":"\u00c1lvarez Flores","sequence":"first","affiliation":[{"name":"Centro Nacional de Investigaciones Cardiovasculares Carlos III, 28029 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Sope\u00f1a Corvinos","sequence":"additional","affiliation":[{"name":"URSalud Laboratory, Hospital Universitario Infanta Sofia, 28702 San Sebasti\u00e1n de los Reyes, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0714-5424","authenticated-orcid":false,"given":"Raquel","family":"Guill\u00e9n Santos","sequence":"additional","affiliation":[{"name":"URSalud Laboratory, Hospital Universitario Infanta Sofia, 28702 San Sebasti\u00e1n de los Reyes, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Cava Valenciano","sequence":"additional","affiliation":[{"name":"URSalud Laboratory, Hospital Universitario Infanta Sofia, 28702 San Sebasti\u00e1n de los Reyes, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,11,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/cyto.b.21724","article-title":"Use of flow cytometry in the phenotypic diagnosis of hodgkin\u2019s lymphoma","volume":"96","author":"Grewal","year":"2019","journal-title":"Cytom. B Clin. Cytom."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/cyto.b.21265","article-title":"Immunophenotype of normal vs. myeloma plasma cells: Toward antibody panel specifications for MRD detection in multiple myeloma","volume":"90","author":"Tute","year":"2016","journal-title":"Cytom. B Clin. Cytom."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/cyto.b.21239","article-title":"Principles of minimal residual disease detection for hematopoietic neoplasms by flow cytometry","volume":"90","author":"Wood","year":"2016","journal-title":"Cytom. B Clin. Cytom."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1182\/blood-2007-11-120535","article-title":"Flow cytometric immunophenotyping for hematologic neoplasms","volume":"111","author":"Craig","year":"2008","journal-title":"Blood"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1309\/AJCPW9TSLQNCZAVT","article-title":"Flow cytometry rapidly identifies all acute promyelocytic leukemias with high specificity independent of underlying cytogenetic abnormalities","volume":"135","author":"Dong","year":"2011","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1126\/science.2218500","article-title":"Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17","volume":"249","author":"Borrow","year":"1990","journal-title":"Science"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41408-021-00514-3","article-title":"Acute promyelocytic leukemia current treatment algorithms","volume":"11","author":"Yilmaz","year":"2021","journal-title":"Blood Cancer J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1182\/blood-2008-04-150250","article-title":"Management of acute promyelocytic leukemia: Recommendations from an expert panel on behalf of the European LeukemiaNet","volume":"113","author":"Sanz","year":"2009","journal-title":"Blood"},{"key":"ref_9","first-page":"405","article-title":"The flow cytometric pattern of CD34, CD15 and CD13 expression in acute myeloblastic leukemia is highly characteristic of the presence of PML-RARalpha gene rearrangements","volume":"84","author":"Orfao","year":"1999","journal-title":"Haematologica"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"134","DOI":"10.5581\/1516-8484.20120033","article-title":"Molecular basis for the diagnosis and treatment of acute promyelocytic leukemia","volume":"34","author":"Bassi","year":"2012","journal-title":"Rev. Bras. Hematol. Hemoter."},{"key":"ref_12","first-page":"533","article-title":"Diagnosis and management of acute promyelocytic leukemia: Brazilian consensus guidelines 2024 on behalf of the Brazilian Association of Hematology, Hemotherapy and Cellular Therapy","volume":"46","author":"Catto","year":"2024","journal-title":"Hematol. Transfus. Cell Ther."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1182\/blood.V86.6.2403.bloodjournal8662403","article-title":"Neutrophil Fc\u03b3RIIIb Deficiency, Nature, and Clinical Consequences: A Study of 21 Individuals From 14 Families","volume":"86","author":"Haas","year":"1995","journal-title":"Blood"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2362.2004.01298.x","article-title":"Genetic deficiency of CD16, the low-affinity receptor for immunoglobulin G, has no impact on the functional capacity of polymorphonuclear neutrophils","volume":"34","author":"Wagner","year":"2004","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1182\/blood.V36.2.145.145","article-title":"Paroxysmal nocturnal hemoglobinuria: Evidence for monoclonal origin of abnormal red cells","volume":"36","author":"Oni","year":"1970","journal-title":"Blood"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.7680492","article-title":"The cloning of PIG-A, a component in the early step of GPI-anchor biosynthesis","volume":"259","author":"Miyata","year":"1993","journal-title":"Science"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/cyto.b.20151","article-title":"Diagnosing PNH with FLAER and multiparameter flow cytometry","volume":"72","author":"Sutherland","year":"2007","journal-title":"Cytom. B Clin. Cytom."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/cyto.b.20525","article-title":"Guidelines for the diagnosis and monitoring of paroxysmal nocturnal hemoglobinuria and related disorders by flow cytometry","volume":"78","author":"Borowitz","year":"2010","journal-title":"Cytom. B Clin. Cytom."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1309\/AJCPMRDZZFQM7YJ4","article-title":"Use of a FLAER-based WBC assay in the primary screening of PNH clones","volume":"132","author":"Sutherland","year":"2009","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/ajcp\/114.3.459","article-title":"Improved detection and characterization of paroxysmal nocturnal hemoglobinuria using fluorescent aerolysin","volume":"114","author":"Brodsky","year":"2000","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Chen, Y., Tong, X., Lu, R., Zhang, Z., and Ma, T. (2024). All-trans retinoic acid in hematologic disorders: Not just acute promyelocytic leukemia. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1404092"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e24145","DOI":"10.1002\/jcla.24145","article-title":"The expression and clinical significance of CD59 and FLAER in Chinese adult AML patients","volume":"36","author":"Li","year":"2022","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_23","first-page":"86","article-title":"A new approach to the study of Hodgkin lymphoma by flow cytometry","volume":"55","author":"Corvinos","year":"2023","journal-title":"Pathology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/cyto.a.20333","article-title":"Flow cytometry controls, instrument setup, and the determination of positivity","volume":"69","author":"Maecker","year":"2006","journal-title":"Cytom. A"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/22\/11898\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:26:53Z","timestamp":1760113613000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/22\/11898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,5]]},"references-count":24,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["ijms252211898"],"URL":"https:\/\/doi.org\/10.3390\/ijms252211898","relation":{},"ISSN":["1422-0067"],"issn-type":[{"type":"electronic","value":"1422-0067"}],"subject":[],"published":{"date-parts":[[2024,11,5]]}}}